Navigation Links
Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis

on Form 20-F and its other filings with the U.S. Securities and Exchange Commission. Forward-looking statements speak only as of the date on which they are made and the Company undertakes no obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.

Contact

Teva Neuroscience
John Shaw, 816-508-5062
john.shaw@tevaneuro.com


'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Point of Care Strep Tests Speed Treatment, Lower Costs
2. Rapid HIV Testing Increases Possibility of Treatment
3. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
4. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
5. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
6. BusinessWeek Article Highlights Promising Breakthrough Treatment for Advanced Coronary Artery Disease
7. TransPharma Medical Announces Positive Results of Phase I Clinical Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis Treatment
8. TMC125 Showed Significant Virologic Response at Week 24 in Treatment-Experienced HIV Patients With NNRTI Resistance in Phase 3 Trials
9. New Phase 3 Study Published in The Lancet Evaluates Efficacy and Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination Therapy in Treatment-Experienced Adults With HIV
10. BusinessWeek Article Highlights Promising Breakthrough Treatment for Advanced Coronary Artery Disease
11. Peer Reviewed Journal Article Indicates Repros Proellex Exhibits Potential for New Approach to the Treatment and Prevention of Breast Cancer
Post Your Comments:
(Date:7/22/2014)... DIEGO , July 22, 2014  Halozyme Therapeutics, ... it has resumed enrollment and dosing of patients in ... in patients with pancreatic cancer under the revised clinical ... is an investigational PEGylated form of Halozyme,s proprietary recombinant ... tumors that accumulate hyaluronan. "Our diligent ...
(Date:7/22/2014)... YORK , July 22, 2014 /PRNewswire-iReach/ -- ... New York ), a nationally and ... for patients requiring reproductive assistance, is pleased to announce ... Corps and Compassionate Care Programs to recognize the sacrifices ... The Compassionate Corps Program will allow qualifying ...
(Date:7/22/2014)... , July 22, 2014 The steady ... is spreading to previously rep-friendly specialties, according to ... and marketing consulting firm ZS Associates.      ... 200 U.S. pharmaceutical sales teams. The report examines ... meet with the pharmaceutical sales reps who visit ...
Breaking Medicine Technology:Halozyme Resumes Patient Enrollment And Dosing In PEGPH20 Clinical Program In Pancreatic Cancer 2Halozyme Resumes Patient Enrollment And Dosing In PEGPH20 Clinical Program In Pancreatic Cancer 3Reproductive Medicine Associates of New York Collaborates with EMD Serono to Offer Treatment Assistance to Eligible Veterans and their Spouses 2Reproductive Medicine Associates of New York Collaborates with EMD Serono to Offer Treatment Assistance to Eligible Veterans and their Spouses 3Even traditionally rep-friendly specialists will see fewer pharmaceutical sales reps this year, according to ZS Associates 2Even traditionally rep-friendly specialists will see fewer pharmaceutical sales reps this year, according to ZS Associates 3Even traditionally rep-friendly specialists will see fewer pharmaceutical sales reps this year, according to ZS Associates 4Even traditionally rep-friendly specialists will see fewer pharmaceutical sales reps this year, according to ZS Associates 5
... ("Senesco" or the "Company") (NYSE Amex: SNT ) ... conducted in Dr. William Scheld,s lab at the University of ... against Senesco,s Factor 5A gene had a 52% survival rate as ... treatment or a control siRNA.A total of 73 mice were infected ...
... announced today that eleven presentations or publications on pre-clinical ... in several major tumor types will be made during ... Meeting, May 29-June 2, in Orlando, Florida. Abstracts ... http://www.newscom.com/cgi-bin/prnh/20090227/PH75873LOGO ) Prostate ...
Cached Medicine Technology:Senesco Announces H1N1 Influenza Survival Test Results in Mice 2Senesco Announces H1N1 Influenza Survival Test Results in Mice 3Ascenta Therapeutics Announces Multiple Presentations on AT-101 at 2009 ASCO Annual Meeting 2Ascenta Therapeutics Announces Multiple Presentations on AT-101 at 2009 ASCO Annual Meeting 3
(Date:7/22/2014)... the Clean Plate Club you eat pretty much everything ... A new Cornell University study shows that the average adult ... or her plate. "If you put it on ... Ph.D., author of the forthcoming book, Slim by Design, Professor ... Lab. , Wansink and co-author Katherine Abowd Johnson analyzed 1179 ...
(Date:7/22/2014)... Legislation backed by the drugstore lobby ... Act of 2014”) championing so-called “any willing pharmacy” ... availability of lower cost preferred pharmacy networks and ... next 10 years, according to new research from ... Management Association (PCMA). , The drugstore lobby targets ...
(Date:7/22/2014)... -- New guidelines on cholesterol treatment and cardiovascular risk ... risk of dying from atherosclerotic cardiovascular disease or of ... with a similar risk profile (based on age, smoking ... of this finding for when and how aggressively to ... Journal of Men,s Health , a peer-reviewed publication ...
(Date:7/22/2014)... New York, NY (PRWEB) July 22, 2014 ... Risperdal lawsuits ( http://www.risperdallawsuitcenter.com/ ) in ... his decision to deny punitive damages in cases ... (male breast growth), Bernstein Liebhard LLP reports. In ... New also denied a plaintiffs’ request to certify ...
(Date:7/22/2014)... (HealthDay News) -- One of the largest studies ever ... has uncovered 83 new sites on chromosomes that harbor ... by an international team of researchers, now bring the ... disorder to 108. Although these schizophrenia-associated genes ... to predict who will or will not develop the ...
Breaking Medicine News(10 mins):Health News:PCMA: New Study Finds H.R. 4577 to Cost $21 Billion Over 10 Years 2Health News:Risperdal Lawsuit News: Pennsylvania Judge Won’t Reconsider Denial of Punitive Damages for Risperdal Gynecomastia Plaintiffs, Bernstein Liebhard LLP Reports 2Health News:Risperdal Lawsuit News: Pennsylvania Judge Won’t Reconsider Denial of Punitive Damages for Risperdal Gynecomastia Plaintiffs, Bernstein Liebhard LLP Reports 3Health News:Risperdal Lawsuit News: Pennsylvania Judge Won’t Reconsider Denial of Punitive Damages for Risperdal Gynecomastia Plaintiffs, Bernstein Liebhard LLP Reports 4Health News:Gene Discoveries Could Shed New Light on Schizophrenia 2
... brain cells suddenly went rogue and decided to become fat ... early in an organism,s development, cells make firm and more-or-less ... say, skin cells, brain cells or, well, fat cells. ... the possible candidates encoded in a cell,s genes, the cell ...
... SUNDAY, March 20 (HealthDay News) -- People with asthma may ... according to a new study that looked at the relationship ... which looked at medical records from the late 1960s through ... illness among asthmatics than other people. Researchers led by ...
... ill in Britain, according to new research published today by ... of almost 800 patients with severe mental illness such as ... or obese, and a disproportionate number suffered from diabetes, heart ... results of the two-year project in Kent are published today ...
... HealthDay Reporter , SATURDAY, March 19 (HealthDay News) -- ... quickly as experts previously have believed. In a study ... third outgrew it within 30 months. But that finding ... higher percentage of children outgrowing the allergy fairly quickly, said ...
... Today, during the 89th General Session & Exhibition of ... with the 40th Annual Meeting of the American Association ... the Canadian Association for Dental Research, lead researcher F. ... study titled "Biodegradable Tooth-binding Micelles Inhibit Streptococcus mutans ...
... 18, 2011)--The growing concern surrounding the release of ... in Japan has raised fears of radiation exposure ... plume of radioactivity crossing the Pacific Ocean. To ... American Association of Clinical Endocrinologists (AACE), the American ...
Cached Medicine News:Health News:Stanford researchers discover molecular determinant of cell identity 2Health News:Stanford researchers discover molecular determinant of cell identity 3Health News:Stanford researchers discover molecular determinant of cell identity 4Health News:Study Ties Asthma to Higher Odds for Diabetes, Heart Disease 2Health News:Study Ties Asthma to Higher Odds for Diabetes, Heart Disease 3Health News:Study Ties Asthma to Higher Odds for Diabetes, Heart Disease 4Health News:Life expectancy of severely mentally ill dramatically reduced due to poor physical health 2Health News:Outgrowing Milk Allergy May Take Some Babies Longer Than Expected 2Health News:Outgrowing Milk Allergy May Take Some Babies Longer Than Expected 3Health News:Biodegradable tooth-binding micelles inhibit Streptococcus mutans biofilm growth 2Health News:Radiation risks to health: A joint statement from leading scientific experts 2
... The Answer to Micro-Incision Cataract ... Technology With its unique double-step ... knife is ideal for MICS. ... reproducible incisions that allow you ...
Interchangeable design allows you to select a single handpiece and change tips during the procedure. Universal connector. Disassembles for easy cleaning. Tips can rotate 360 degrees to re-orient port...
Infusion Cannula, 6.0mm....
Subretinal Injection Cannula, Curved; 20g (0.90) x 1" (25mm); Tip Extension: 3mm, 32g (0.23); Angled at 35°....
Medicine Products: